Exercise Biochemistry, Physiology and Nutrition Laboratory, Department of Physical Education and Sport Science, University of Thessaly
Trikala, Thessaly, 42150, Greece
NCT Number: NCT05729659
The aim of the present clinical study is to estimate the efficacy of a Sideritis Scardica extract (SidTea+), derived from the Greek mountain Taygetos, in regulating antioxidant and health biomarkers in healthy adults.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Trikala, Thessaly, 42150, Greece
Introduction: The mountain tea of genus Sideritis has more than 150 species, which are mainly distributed in the Mediterranean area. In the literature, extensive reference is made to the secondary metabolites of Sideritis, the main ones of which are terpenoids (i.e., iridoids and kauranes) and phenolic derivatives (i.e., flavonoids, phenolic acids, phenylethanoid glycosides). Polyphenols exhibit a wide range of biological activities, such as anti-atherogenic, anti-cancer, anti-mutagenic, anti-inflammatory and antimicrobial properties. Among phenolic derivatives, major significance is given to flavonoids, due to their antioxidant, anti-inflammatory, antibacterial, antiviral and anti-allergic properties in various pathologies. Flavonoids mainly act as antioxidants, inhibiting free radical-induced cytotoxicity and lipid peroxidation. Moreover, these compounds are known to inhibit tumor growth and proliferation and act as weak agonists or antagonists of estrogens by regulating endogenous hormonal activity. In these ways, they can protect against chronic diseases such as atherosclerosis and cancer and regulate menopausal symptoms.
Purpose: This study aims to investigate the effect of a Sideritis Scardica extract (SidTea+) supplement from the Greek mountain Taygetos on health and oxidative stress indicators in healthy individuals. The results of the present investigation will help to elucidate the effects of an extract derived from a plant product on markers of health and oxidative stress in apparently healthy individuals.
Methodology: 30 healthy individuals will be enrolled in the study. Participants will give their informed consent after they will be informed about the purposes, procedures, risks and benefits associated with the study. Participants will be randomly allocated to either a Sideritis spp or a placebo supplementation group and they will consume 1500 mg/day of Sideritis or placebo, distributed in three equal doses (every 8 hours) for one month. At baseline and post-intervention, volunteers will be assessed for their anthropometric profile, muscle function and cardiorespiratory capacity and will provide a resting blood sample for the assessment of oxidative stress and health biomarkers. Participants will be asked to record their diet for 3 days prior to the study and they will be asked to follow the same dietary pattern for 3 days before the post-intervention assessments.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1500 mg of Sideritis Scardica (SidTea+) extract per day, divided into 3 equal doses of 500 mg (every 8 hours) for a total duration of 1 month
1500 mg of placebo per day, divided into 3 equal doses of 500 mg (every 8 hours) for a total duration of 1 month
Time frame: Change from baseline to 1 month
Glutathione concentration will be analyzed in erythrocytes
Time frame: Change from baseline to 1 month
Catalase activity will be analyzed in erythrocytes
Time frame: Change from baseline to 1 month
Total antioxidant capacity will be analyzed in serum
Time frame: Change from baseline to 1 month
Thiobarbituric acid reactive substances concentration will be analyzed in plasma
Time frame: Change from baseline to 1 month
Protein carbonyls will be analyzed in plasma
Time frame: Change from baseline to 1 month
Glucose concentration will be analyzed in plasma
Time frame: Change from baseline to 1 month
Cholesterol concentration will be analyzed in plasma
Time frame: Change from baseline to 1 month
triglycerides concentration will be analyzed in plasma
Time frame: Change from baseline to 1 month
High-density lipoprotein concentration will be analyzed in plasma
Time frame: Change from baseline to 1 month
Bilirubin concentration will be analyzed in plasma
Time frame: Change from baseline to 1 month
Lactate dehydrogenase concentration will be analyzed in plasma
Time frame: Change from baseline to 1 month
Serum glutamic-oxaloacetic transaminase will be analyzed in serum
Time frame: Change from baseline to 1 month
Gamma-glutamyl transpeptidase concentration will be analyzed in serum
Time frame: Change from baseline to 1 month
Creatinine concentration will be analyzed in serum
Time frame: Change from baseline to 1 month
Uric acid concentration will be analyzed in serum
Time frame: Change from baseline to 1 month
Handgrip strength will be measured using a hand dynamometer
Time frame: Change from baseline to 1 month
eVO2max will be measured using an automated open-circuit spirometer
Time frame: Change from baseline to 1 month
Body weight will be measured using a digital scale
Time frame: Change from baseline to 1 month
Body fat will be measured by bioelectrical impedance analysis
Time frame: Change from baseline to 1 month
Resting heart rate will be measured using a heart rate sensor
Time frame: Change from baseline to 1 month
Diastolic and systolic blood pressure will be measured using a manual sphygmomanometer
Time frame: Change from baseline to 1 month
Waist and hip circumference will be assessed using a tape measure
Time frame: Change from baseline to 1 month
White blood cells, lymphocytes, monocytes, granulocytes, red blood cells and platelets will be analyzed in whole blood using an automated blood chemistry analyzer
Time frame: Baseline
Protein, carbohydrate and fat dietary intake will be measured using diet recalls (food questionnaires)
Time frame: Baseline
Vitamin C, vitamin E, zinc, methionine and cysteine dietary intake will be analyzed using diet recalls (food questionnaires)
Time frame: Baseline
Low, moderate and vigorous physical activity will be assessed by questionnaires
University of Thessaly
Other
The Effect of Sideritis Scardica (SidTea+) Extract Supplementation on Health and Oxidative Stress Biomarkers in Healthy Individuals
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01267227
Blood Pressure, Dyslipidemias
Jackson, Mississippi, United States
View Trial DetailsNCT00090402
Alzheimer Disease, Alzheimer's Disease
Portland, Oregon, United States
View Trial DetailsNCT01047280
Body Composition, Body Weight
View Trial DetailsNCT07728422
Muscle Damage, Oxidative Stress
Malatya, Turkey (Türkiye)
View Trial Details